Phase 1 Study of ETN101 in Patients With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Advanced Hepatocellular Carcinoma; Liver Cancer Interventions: Drug: ETN101 Sponsors: Etnova Therapeutics Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Study | Urology & Nephrology